Pharmacy

Medicare Part D beneficiaries with serious health conditions and not receiving low-income subsidies can expect to pay anywhere from $2,622 to $16,551 out of pocket for specialty-tier drugs this year, according to a Kaiser Family Foundation analysis.

Tris Pharma expanded a nationwide recall of its infant ibuprofen over concentration issues, according to USA Today.

Members of the House Energy and Commerce Committee sent letters to three leading insulin manufacturers Jan. 30, inquiring about increasing insulin prices.

Sen. Mitt Romney, R-Utah, is scheduled to address one of the pharmaceutical industry's biggest lobbying groups and a handful of industry CEOs during a closed-door meeting Jan. 31, according to STAT News.

Medication non-adherence exacts a heavy toll, both on patients and the broader healthcare industry.

Pharmacy giants CVS and Walgreens are increasingly adding dental services to their drugstores, CNBC reports.

The FDA is performing fewer inspections on generic drug plants, which raises concerns over the safety and quality of generic medications on the market, according to an investigative report from Bloomberg.

The House and Senate held separate hearings Jan. 29 to address high drug prices, according to STAT.

Executives from CVS Health, Surescripts and Cigna will speak about how to make drug price information more accessible at the point of care at HIMSS19, companies said Jan. 28.

Last October, the Trump administration released a slew of proposals aimed at lowering the costs of drugs in the U.S., one of which included establishing an international pricing index that would set reimbursement prices for pharmaceutical products based on what…